In the race to forge the next Keytruda from PD-(L)1xVEGF bispecific antibodies, Pfizer and the BioNTech-Bristol Myers Squibb alliance are split on how to position overall survival—the gold-standard ...
MedPage Today on MSN
Adding immunotherapy-based combo boosts PFS in unresectable liver cancer
But is the higher incidence of grade 3/4 adverse events "a worthwhile price to pay?" exper ...
In the run-up to Pre-Filled Syringes West Coast in June, SMi Group caught up with Douglas Cusato from Sumitomo Rubber to discuss his presentation, current challenges and the upcoming event. A: “The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results